a month ago
BLTE
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Abcellera Biologics IncABCL | +133.69% | $4.66 | $10.89 | 2026-05-05 - 2026-09-11 | Strong Buy |
Apellis Pharmaceuticals IncAPLS | +125.77% | $17.89 | $40.39 | 2026-03-18 - 2026-04-01 | Strong Buy |
Xencor IncXNCR | +107.04% | $11.79 | $24.41 | 2025-10-06 - 2026-09-11 | Strong Buy |
Apellis Pharmaceuticals IncAPLS | +89.36% | $21.33 | $40.39 | 2026-01-13 - 2026-04-01 | Strong Buy |
Apellis Pharmaceuticals IncAPLS | +78.78% | $22.95 | $41.03 | 2025-08-01 - 2026-05-15 | Strong Buy |
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Belite Bio IncBLTE | 3 | Strong Buy | $270.00 | +55.36% | Maintains | a month ago |
Innoviva IncINVA | 3 | Strong Buy | $34.00 | +64.57% | Maintains | a month ago |
Inflarx NvIFRX | 2 | Strong Buy | $6.00 | +187.08% | Maintains | a month ago |
Eyepoint IncEYPT | 2 | Strong Buy | $55.00 | +1,200.24% | Maintains | a month ago |
Xencor IncXNCR | 3 | Strong Buy | $44.00 | +80.25% | Maintains | a month ago |
Abcellera Biologics IncABCL | 2 | Strong Buy | $12.00 | +10.19% | Maintains | a month ago |
Aligos Therapeutics IncALGS | 1 | Strong Buy | $20.00 | +283.14% | Initiates Coverage On | 4 months ago |
Harrow IncHROW | 3 | Strong Buy | $88.00 | +155.22% | Maintains | 4 months ago |
Viking Therapeutics IncVKTX | 1 | Strong Buy | $100.00 | +212.70% | Maintains | 4 months ago |
Apellis Pharmaceuticals IncAPLS | 4 | Hold | N/A | N/A | Downgrades | 5 months ago |
Opus Genetics IncIRD | 1 | Strong Buy | $15.00 | +148.34% | Initiates Coverage On | 5 months ago |
Surrozen IncSRZN | 2 | Strong Buy | $40.00 | +110.53% | Reiterates | 6 months ago |
Korro Bio IncKRRO | 3 | Strong Buy | $22.00 | +59.30% | Maintains | 6 months ago |
Wave Life Sciences IncWVE | 2 | Strong Buy | $41.00 | +793.25% | Maintains | 7 months ago |
Camp4 Therapeutics CorpCAMP | 1 | Strong Buy | $7.00 | +64.71% | Initiates Coverage On | a year ago |
Tvardi Therapeutics IncTVRD | 1 | Strong Buy | $52.00 | N/A | Initiates Coverage On | a year ago |